[ET Net News Agency, 30 March 2020] Sinopharm Group Co. Ltd. (01099) said its profit
attributable to owners of the parent was RMB6.25 billion for the year ended 31 December
2019, a year-on-year increase of 7.14%. The basic earnings per share were RMB2.11. A final
dividend of RMB0.6 will be distributed.
The revenue was RMB425.27 billion, a year-on-year increase of 23.44%. (RC)